<DOC>
	<DOC>NCT00380744</DOC>
	<brief_summary>The purpose of this study is to examine the safety and efficacy of this antibody in rheumatoid arthritis patients. Part A of the study is an initial dose escalation phase Part B of the study is a randomized allocation of the entire dosing group to parallel treatment assignments</brief_summary>
	<brief_title>A Safety and Pharmacokinetics Study in Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>diagnosis of rheumatoid arthritis regular use of methotrexate active rheumatoid arthritis Juvenile Rheumatoid Arthritis evidence of tuberculosis women who are pregnant or become pregnant during study, or are breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>